-+ 0.00%
-+ 0.00%
-+ 0.00%

Prelude Therapeutics initial beneficial ownership statement names RA Capital Management

PUBT·04/28/2026 21:24:38
Listen to the news
Prelude Therapeutics initial beneficial ownership statement names RA Capital Management
  • RA Capital Management filed Form 3 disclosing beneficial ownership of 7,882,882 Prelude Therapeutics common shares.
  • Filing lists RA Capital as a 10% owner, with event date April 21, 2026.
  • Shares are reported as indirectly owned through RA Capital Healthcare Fund.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prelude Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231919-26-000420), on April 28, 2026, and is solely responsible for the information contained therein.